Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Ezine Publishing > Ezine Publishing - Keeping Your Subscribers Reading Your Emails

Tags

  • involved
  • pharmaceutical
  • products
  • developing combination

  • Links

  • Global Waming Changes
  • Download Free Anti Spyware Software with Google Pack
  • Savings Accounts ??“ Retire In Style
  • Main Subject - Ezine Publishing - Keeping Your Subscribers Reading Your Emails

    One of the hardest challengers for an ezine publisher is to keep your su
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    bscribers reading your emails. You are only really in business when you
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    subscribers are reading your emails. If you are selling a product your
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    self, if your subscribers are not reading your emails, they are not buyi
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    g your products. If you are selling advertising and solo ads, if your s
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    bscribers are not reading your emails, you are not selling a lot of adve
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    rtising because the advertisers don’t like the response they are getting
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi


    So how do you keep your readership high?

    I think that one of the most
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    important things is credibility. Your subscribers have to consistently
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    receive value when they read your emails, or they will stop opening them
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    stop reading them, and stop clicking through to the links in them. You
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    must make sure that you never mail anything that does not give the subsc
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    riber value. Make sure that the subject line matches the content of the
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    emails – no trickery. If you trick your subscribers into opening an ema
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    l they would not like to if they knew what was really in it, you get uns
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ubscribes and people quit opening your emails.

    Another thing to do is t
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    keep the readership involved. Ask them questions, then answer the ques
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ions mailbag style, so everyone can see that you are communicating with
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    your list. If you do this, some subscribers will actually look forward
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    o receiving your email, rather than deleting it as soon as it comes over


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/63264/mainsubjects-Ezine-Publishing--Keeping-Your-Subscribers-Reading-Your-Emails.html">Ezine Publishing - Keeping Your Subscribers Reading Your Emails</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/63264/mainsubjects-Ezine-Publishing--Keeping-Your-Subscribers-Reading-Your-Emails.html]Ezine Publishing - Keeping Your Subscribers Reading Your Emails[/url]

    Related Articles:

    Double the Effectiveness of Your Company Brochure

    Gmail is the Way to Go

    The Benefits and Advantages of Ebooks

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com